Results

eNauka >  Results >  Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Title: Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Authors Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S.  ; ...; (broj koautora 23)
Issue Date: 2021
Publication: The Lancet. Oncology
ISSN: 1470-2045 Lancet Oncology Search Idenfier
Publisher: London : Lancet Pub. Group
Type: Article
Collation: vol. 22 br. 6 str. 801-812
DOI: 10.1016/S1470-2045(21)00128-5
WoS-ID: 000657432100048
Scopus-ID: 2-s2.0-85107139896
PMID: 34087126
URI: https://enauka.gov.rs/handle/123456789/822958
URL: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00128-5/abstract
Project: European Myeloma Network
Janssen Research and Development
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

323
SCOPUSTM
172
PubMed CentralTM
294
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.